Performance of the collaborative commercialization strategy: Strategic alliance
Introduction: The biopharmaceutical industry has several notable characteristics such as high R&D costs of $ 125 million to $ 250 million per drug, long-term commercialization cycles, and very complex and often long-term legislative procedures. All of these are associated with a high level of in...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | fas |
| Published: |
Yazd University
2022-01-01
|
| Series: | کاوشهای مدیریت بازرگانی |
| Subjects: | |
| Online Access: | http://bar.yazd.ac.ir/article_2620_d50b5437ebb9a32e99bf13772de78109.pdf |